AI Verdict
LIANY has stronger fundamentals based on our AI analysis.
LILAB vs LIANY Fundamental Comparison
| Metric | LILAB | LIANY |
|---|---|---|
| Revenue | $4.4B | $7.9M |
| Net Income | $-611.2M | $-69.7M |
| Net Margin | -13.8% | -886.0% |
| ROE | -110.0% | -34.4% |
| ROA | -5.0% | -26.5% |
| Current Ratio | 1.14x | 10.06x |
| Debt/Equity | 14.89x | 0.00x |
| EPS | $-3.06 | $-0.65 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LILAB vs LIANY: Frequently Asked Questions
Is LILAB or LIANY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LIANY has stronger fundamentals. LILAB is rated STRONG SELL (88% confidence) while LIANY is rated SELL (72% confidence). This is not investment advice.
How does LILAB compare to LIANY fundamentally?
Liberty Latin America Ltd. has ROE of -110.0% vs LianBio's -34.4%. Net margins are -13.8% vs -886.0% respectively.
Which stock pays higher dividends, LILAB or LIANY?
LILAB has a dividend yield of N/A or no dividend while LIANY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LILAB or LIANY for long term?
For long-term investing, consider that LILAB has STRONG SELL rating with 88% confidence, while LIANY has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LILAB vs LIANY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LILAB vs LIANY, the AI consensus favors LIANY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.